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Objective: To review the mechanisms believed to be important in the development of vein graft stenosis, with particular 
attention placed on the adaptation of saphenous vein endothelium to a new haemodynamic environment. 
Design and methods: Discussion based on review of published research. 
Results: The aetiology of vein graft stenosis remains to be established and appears to be multi-factorial. The increasing 
evidence for an important role of haemodynamic forces is discussed, particularly via the interaction of these forces with 
the endothelium. 
Conclusion: Further understanding of the interaction between haemodynamic forces, blood constituents and the newly 
implanted vein graft is required. Use of in vitro models i  contributing increasing knowledge tothis area," but ultimately 
better non-invasive methods of assessing haemodynamic forces in vivo are required. 
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Introduction 
Lower limb ischaemia is a common problem, with 
around 20 000 cases presenting annually in the U.K. 1 
Bypass surgery is the principal therapy for severe 
lower limb ischaemia, with around 7000 infrainguinal 
bypass grafts performed annually in the U.K .  2 
Infrainguinal Vein Bypass 
Vein bypass has been demonstrated to give better 
results than prosthetic bypass for femorodistal bypass. 3 
However, even for vein bypass there is a considerable 
failure rate: around 20-30% of infrainguinal vein by- 
pass grafts occlude or require revision within i year of 
surgery. 4-15 Graft occlusion within I month of operation 
has been reported in between 5and 10% of vein grafts, 
and accredited to technical problems at the operation, 
poor patient selection and hypercoagulable states. 
However, it is possible that early graft occlusion rates 
are under-reported, as some reports document much 
higher early occlusion rates. 16 The majority of primary 
graft failures are reported between 1 and 12 months 
as a results of vein graft stenosis (Table 1). In this 
review the aetiology of such graft stenoses i discussed, 
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particularly in relationship to the response of the 
endothelium to changes in haemodynamic forces. 
Vein Bypass 
In order to perform vein bypass the conduit is exposed 
to a variety of potentially injurious procedures. For in 
situ bypass the principal procedure is passage of a 
valvutome to render the valves incompetent, while for 
reversed bypass the vein is excised, stored in a variety 
of solutions, and usually distended by intraluminal 
infusion to check for side branch leaks and overcome 
spasm. These manoeuvres lead to endothelial cell loss 
and functional impairment, plus medial damage. 17-24 
For example, harvesting of saphenous vein has been 
demonstrated to result in impairment in the release of 
the important inhibitor of smooth muscle proliferation, 
nitric oxideY 
Perhaps the most important change following vein 
grafting is the exposure of saphenous vein to the 
arterial circulation. In the venous circulation sa- 
phenous vein is subjected to low pressure, non-puls- 
atile flow and a shear stress of around 0.2 dyne/cm 2.
Following grafting the vein is exposed to high pressure, 
pulsatile flow and a shear stress of approximately 3-6 
dynes/cm 2. In addition to increased shear stress the 
vein is subjected to a variety of other new haemo- 
dynamic forces, including radial and circumferential 
deformation (Fig. 1). 26 
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Fig. 1. Haemodynamic forces imposed on the new vein graft. Following implantation vein grafts are exposed to increased flow (shear 
stress), radial and circumferential stretch, both in a static and pulsatile manner. 
The Aetiology of Vein Graft Stenosis 
Mechanisms which have been part icularly implicated 
in the deve lopment  of vein graft stenosis include injury 
to the vein dur ing harvest ing and anastomosis, the 
haemodynamic  changes fol lowing grafting, interaction 
between the vein and blood constituents and pre- 
existing disease in the vein conduit. 27'2s It appears likely 
that all these factors interact to p lay a role in the 
deve lopment  of graft stenosis. 
Pre -ex is t ing  venous  d i sease  
While intimal hyperplasia develops throughout  he 
vein graft72 graft stenoses represent localised ex- 
aggerated foci of intimal hyperplas ia at the ana- 
stomoses or in the body  of the graft (Table 1). Most 
Saphenous veins used as bypass conduits have some 
degree of pre-existing intimal thickening and medial  
fibrosis. 29 Veins with more severe pre-existing disease 
appear to be at higher risk of stenosis and occlusion. 
Table 1. Vein graft stenoses identified and treated in selected surveillance series. 
Reference Grafts Follow Stenosed Proximal Body Distal Grafts Surgery: Recurrences 
up grafts graft treated PTA 
Grigg et al. 4 80 12 19 7 10 2 5 4:01 NG 
Berkowitz et aL 6 521 120 109 29 61 19 72 17:55 23 
Disselhoff et al. 7 77 12 16 1 15 0 12 12:00 1 
Thompson et al. 8 110 13 14 4 4 7 14 4:10 11 
Mills et al. 9 379 21 48 18 23 8 48 46:2 2 
Moody et al. 1° 63 12 15 2 9 7 8 0:08 0 
Bandyk et al. ~ 396 12 83 29 41 15 83 71:12 28 
London et al. 13 112 19 30 8 7 18 28 4:24 10 
Lundell et al. 15 56 36 9 4 2 3 9 8:01 NG 
Total 1794 343 (19%) 102 (29%) 172 (49%) 79 (22%) 279 (16%) 166:113 75 (27%) 
NG = not given; PTA = percutaneous transluminal angioplasty. 
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Davies et al. 3° showed that pre-existing intimal thick- 
ening was associated with decreased vein wall com- 
pliance and an increased risk of the subsequent 
development of vein graft stenosis. 
Injury during harvesting and anastomosis 
The endothelial and medial damage resulting from 
graft preparation and anastomosis by favouring the 
release of smooth muscle mitogenes and diminishing 
the presence of growth inhibitors may favour un- 
controlled smooth muscle proliferation characteristic 
of intimal hyperplasia. 3~'32 Studies in vitro suggest endo- 
thelial injury may have a role in promoting intimal 
thickening. 32 However, injury alone appears in- 
sufficient o stimulate the local development of sten- 
osis. Moody et al. 33 demonstrated no association 
between the site of vein graft stenoses, defined using 
angiography, and the marked site of valves, tributary 
ligation, and clamp placement. The very different in- 
juries involved in performing reversed and in situ vein 
grafts are associated with comparable results both in 
terms of patency and stenoses. 34
Plasma factors 
A number of studies have demonstrated high plasma 
fibrinogen concentration tobe significantly associated 
with infrainguinal vein graft occlusion and stenosis. 35-37 
Wiseman and colleagues tudied 157 patients fol- 
lowing infrainguinal vein bypass. 35 One-year patency 
for patients with below median fibrinogen con- 
centration was 90% compared to 57% for patients with 
above median fibrinogen concentration (p<0.0002). 35
Smoking was also associated with vein graft occlusion, 
but at a less significant level: the 1-year patency was 
84% for non-smokers (serum thiocyanate<70 gmol/1) 
and 63% for smokers (serum thiocyanate>70 gmol/1), 
p =0.02. These two factors of plasma fibrinogen and 
smoking are not unrelated, as smoking is associated 
with raised plasma fibrinogen levels. 38 
Hicks et al. studied 75 patients following infra- 
inguinal vein bypass with duplex surveillance to 
identify factors associated with graft stenosis. 37 From 
a range of patient and biochemical factors assessed by 
multiple regression analysis, high plasma fibrinogen 
was identified as the single factor associated with graft 
stenosis (p = 0.003). By life-table analysis, only 46% of 
grafts remained free of stenosis in patients with above 
median fibrinogen concentrations compared with 84% 
of grafts in patients with below median fibrinogen 
concentrations at I year. 37 Cheshire t al. also found an 
association between plasma fibrinogen concentration 
and vein graft stenosis. 39 The authors studied the 
factors associated with occlusion or stenosis of 79 
infrainguinal bypass grafts; however, this was a mixed 
series where 56 were vein grafts and 23 prosthetic 
grafts. Smoking, plasma fibrinogen, and plasma 5- 
hydroxy-tryptamine w re associated with graft sten- 
osis on univariate analysis, at a similar level, p = 0.001, 
with no multi-variate analysis performed. 39
Other plasma factors such as hyperlipidaemia have 
been associated with graft occlusionS5; however, at a 
less significant level than fibrinogen. More recently, 
hyperhomocysteinaemia has been suggested as a risk 
factor for the development of vein graft stenosis. 4°
The series assessed was a small selected group of 18 
patients, and this requires confirmation in a larger 
prospective study. 
Haemodynamic forces 
The initial alterations in haemodynamic forces im- 
posed on vein grafts have effects on medial and intimal 
structure (Fig. 1). Studies in animal models have shown 
that vein grafts develop intimal and medial thickening 
all along the graft. Intimal thickening is associated 
most closely with low flow velocity (shear stress), 
whereas medial thickening is associated with increased 
deformation of the vein wall in the circumferential 
direction. 26'41'42 These changes in vein grafts are re- 
versible, at least in the short term, because if the graft 
is returned to the venous circulation within 2 weeks 
the intimal thickening reduces. 43 Grafts placed for 
longer periods in the arterial circulation do not appear 
to exhibit this regression of intimal hyperplasia. 44
A study by Fillinger et al. 4s suggests a similar as- 
sociation between shear stress and intimal thickening 
in human vein grafts. Duplex studies revealed that 
whereas at 1 week after grafting there was a large 
range of vein luminal diameters, by 12 months large 
veins had decreased in diameter and small veins in- 
creased in diameter. The best predictor of diameter 
change was shear stress. This association between vein 
graft intimal thickening and shear stress may simply 
reflect the normal adaptation of vessels to chronic 
changes in flow as described for arteries. 46'47 Thus, 
increased flow velocity results in vessel enlargement 
until lumen radius results in restitution of normal 
baseline wall shear levels, 48 whereas reduction in flow 
velocity may result in lumen narrowing to achieve the 
same goal. 49 
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This generalised intimal and medial thickening that 
occurs in all vein grafts is of little importance compared 
to the localised, haemodynamically significant sten- 
oses that develop in around 30% of vein grafts. How- 
ever, haemodynamic factors appear to be play an 
equally important role in the aetiology of these more 
aggressive types of intimal thickening, particularly in 
the case of vein graft stenoses developing near the 
arterial-venous anastomosis. It is possible that vein 
graft stenoses result from persistent abnormal f ow and 
distribution of shear stress which the vessel attempts to 
correct by progressive intimal thickening, s°
The shear stress distribution at anastomoses has 
been mapped in detail in plastic models. 51 In end-to- 
end anastomoses there are few areas of abnormal 
shear, whereas at end-to-side anastomoses there are 
areas of abnormally high and low shear stress, 2 A 
number of studies in animal models have dem- 
onstrated that sites coincident with mapped low shear 
stress are associated with increased evelopment of 
intimal hyperplasia. 46"53a4 At end-to-side vein graft ana- 
stomoses intimal hyperplasia develops at the suture 
line, heel and toe of the graft and the floor of the 
recipient vessel. Whereas the suture line hyperplasia is
associated with compliance mismatch, and is therefore 
more prominent in prosthetic graft anastomoses, 5° the 
arterial floor and heel and toe hyperplasia coincide 
with sites of low shear stress. 5°'55 Inability to accurately 
measure shear stress and other haemodynamic forces 
non-invasively in vivo has hampered further study of 
the role of these forces in the development of graft 
stenosis. 
Possible Mechanisms Linking Haemodynamic 
Forces and Vein Graft Thickening 
The mechanism by which the vessel responds to 
altered wall shear and tensile stress by changes in 
structure is unknown, but is likely to involve per- 
ception of abnormal shear stress by endothelial cells 
and subsequent transmission of a biological signal to 
the media via release of mediators. 45Sites of low 
shear stress may also encourage platelet and leukocyte 
adhesion, resulting in high local concentration of cyto- 
kines and growth factors likely to stimulate smooth 
muscle cell proliferation and migration into the in- 
tima. 55'56 There is evidence from in vitro studies that 
haemodynamic forces have an important influence 
on endothelium-leukocyte and endothelium-platelet 
interactions, in addition to affecting the endothelial 
synthesis of important growth factors uch as fibroblast 
growth factor, prostacyclin and nitric oxide. It is likely 
that haemodynamic forces also have important effects 
on smooth muscle cell phenotype. 
Endothelial-blood constituent interactions and intimal 
hyperplasia 
Following vein grafting there is rapid deposition of 
leukocytes, platelets and other blood components. 56'57 
These accumulating cells and blood components may 
have an important influence on the later development 
of intimal hyperptasia~ In the experimental situation 
inhibiting leukocyte accumulation using an antibody 
to CD4 results in a reduction in the development 
of intimal hyperplasia, 58 while reduction in platelet 
aggregation using an antibody to GP IIb-IIIa has been 
shown to reduce the incidence of restenosis following 
coronary angioplasty in vivo. 59"60 Monocytes may be 
particularly important. Studies of excised vein graft 
stenoses has demonstrated an abundance of pro- 
liferating monocytes and macrophages in the intima 
of these lesions. 61'62 Leukocytes can release cytokines, 
oxygen-derived free radicals and lysosomal pro- 
teinases, which, by direct effects on smooth muscle 
cells and also modulation of endothelial products, e.g. 
inactivation of nitric oxide, may influence smooth 
muscle cell proliferation and migration. 27'63 Similarly 
deposited platelets release smooth muscle mitogens, 
such as platelet derived growth factor, which en- 
courage smooth muscle cell proliferation and mi- 
gration into the intima. 64 
Studies in cultured cells have demonstrated that 
haemodynamic forces have an important influence on 
the endothelial expression of molecules controlling 
leukocyte and platelet adhesion. Thus it is tempting to 
explain the association between haemodynamic forces 
and vein graft thickening by their effect on the ac- 
cumulation of blood elements. 
Platelet-endothelial Interactions 
Platelets possess a number of cell adhesion molecules 
such as GPIb (mediates endothelial adhesion) and 
GPIIb/IIIa (fibrinogen receptor). Following endo- 
thelial injury, GPlb mediates the initial binding of 
platelets to von Willebrand factor, resulting in ac- 
tivation of GPIlb/IIIa with platelet aggregation. 65.7 
GPIIb/IIIa can then bind fibrinogen, vitronectin and 
thrombospondin, facilitating platelet aggregation. 65'6s' 
69 Platelet activation and adhesion to the endothelium 
is influenced by a number of endothelial products. For 
example, nitric oxide and prostacyclin (PGI2) inhibit, 
while thromboxane A2 stimulates, platelet adhesion 
and aggregation. 7°-74 The synthesis of these molecules 
is influenced by the haemodynamic forces imposed 
on the endothelium. Both shear stress and cyclic strain 
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Fig. 2. Endothelial control of leukocyte adhesion and transmigration. Initial adhesion is controlled by P and E selectin, whereas firm 
adhesion requires ICAM-1 and VCAM-1. PSGL-I: P-selectin glycoprotein ligand, ESL-I: E-selectin ligand. 
have been demonstrated to stimulate increased ex- 
pression of nitric oxide synthase (NOS) and release of 
nitric oxide. 75'76 PGI2 is also shear stress responsive, 
and application of shear stress to HUVECs induces a 
significant increase in PGI2 release. 77'78 These changes 
are likely to inhibit platelet adhesion and aggregation. 
Leukocyte Adhesion and Shear Stress 
Normaily, leukocytes areheld in the central stream of 
laminar flowing blood. At sites of disturbed flow or 
in small vessels leukocytes may be drawn into the 
outer stationary stream. However, for transmigration 
to occur an ordered set of interactions has to take 
place between the endothelium and leukocyte, 79-82 Fig. 
2. The first step is a relatively low strength interaction 
which results in leukocytes rolling slowly along the 
endothelial lining a-87 (see review by McEverS7). This 
adhesion step has been shown to involve interaction 
between leukocyte ligands L selectin and endothelial 
E and P selectin, s1'88-91 More stable adhesion is en- 
couraged by leukocyte chemotactic agents released 
from the endothelium, such as monocyte chemotactic 
factor (MCP-1). 92 Firm adhesion is required before 
transmigration can take place, and this involves 
distinct ligands: ~2 (CD18) integrins on leukocytes 
and their counter-receptors on endothelial cells of 
the immunoglobulin gene superfamily (ICAM-1, 
VCAM-1). 93'94 These ligands can only effect adhesion 
under static conditions or when binding has been 
initiated by selectins. 9°
Increased flow by increasing shear stress mech- 
anically opposes leukocyte adhesion; however, this can 
still take place in vivo at levels of shear stress up to 30 
dynes/era2. 95'96 This may reflect he multitude of more 
complex effects hear stress exerts on the endothelial 
cell. 97 Studies on cultured human umbilical endothelial 
cells (HUVEC), bovine aortic endothelial cells 9g'99 and in 
animal models 95'96 have demonstrated that alterations 
in shear stress influence the expression of endothelial 
adhesins. Expression of ICAM-1 has been shown to in- 
crease in response to laminar shear s t ress .  1°°-1°4 Studies 
investigating the response of VCAM-1 to shear stress 
have given conflicting results, with some investigators 
reporting a decreased expression i  response to shear 
stress 1°2'1°5-1°7 while others find no change 1°°'1°3 and one 
study reporting an increase xpression. TM E-selectin ap- 
pears to be unaffected by alteration i  shear stress. 1°°-1°2 
Because alterations in haemodynamic forces have 
such wide-ranging effects, it is difficult to assess the 
importance ofany single response on overall leukocyte 
adhesion. The effect of shear stress on leukocyte bind- 
ing to cultured endothelial cells has been studied. 
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Morigi et al. 1°1 demonstrated nhanced leukocyte ad- 
hesion to HUVECs pre-exposure to laminar shear 
stress (8 dynes/cm 2 for 6 h). AntMCAM-1 completely 
blocked this flow-enhanced a hesion. However, nitric 
oxide synthesis and release is also shear stress re- 
sponsive 75'I°8 and inhibits leukocyte adhesion. 1°9'~° Tsao 
and colleagues m reported that cultured endothelial 
cells (bovine and human aortic, and human venous) 
previously exposed to laminar flow for only 30 min 
exhibited a 50% reduction in adhesiveness for a mono- 
cyte cell line (THP-1). The effect of flow was abolished 
by a NOS inhibitor (nitro-L-arginine) and a potassium 
channel inhibitor (tetraethylammonium). 
Shear stress and endothelial control of smooth muscle 
growth 
Shear stress has also been demonstrated to influence 
synthesis and release of endothelial products with 
important effects on smooth muscle cell proliferation 
and migration. For example, mRNA levels of the 
smooth muscle cell mitogene PDGF-B is increased four- 
to 13-fold in response to laminar shear stress of 15-36 
dynes/cm 2 in cultured endothelial cells. 112'113 This effect 
is likely counterbalanced by similar upregulation of 
inhibitors of smooth muscle proliferation, such as nitric 
oxide. 1°8 Using an in vitro flow model, both nitric oxide 
synthase and the release of nitric oxide, measured by 
endothelium-dependent r laxation, have been dem- 
onstrated to increase rapidly in saphenous vein endo- 
thelium in response to arterial flow. TM 
Studies of explanted vein grafts have demonstrated 
a great variety of functional alterations in the endo- 
thelium. Many experiments have been performed in 
animal models, and there appear to be species dif- 
ferences in responses to a number of agonistsY -~s 
Studies of explanted human vein grafts have dem- 
onstrated an absence of receptor mediated endo- 
thelium-dependent relaxation; 119'12° however, most of 
the grafts studied have been in situ for many months 
or years, and therefore have developed marked intimal 
hyperplasia. It appears that the venous endothelium 
is still able to synthesise nitric oxide, as endothelium- 
dependent relaxation in response to the calcium ion- 
ophore A23187 is still preserved, even after the grafts 
have been in the arterial circulation for many years. 12° 
Thus, it may be that intimal hyperplasia acts to block 
normally functional receptors in the endothelium from 
mediating NOS activation. Support for this theory 
comes from a study by Ku et al. in which the im- 
pairment of receptor mediated endothelial dependent 
relaxation was shown to increase in line with the 
presence of intimal hyperplasia in coronary vein 
grafts. 121 Recently, evidence has been presented sup- 
porting the preservation of nitric oxide mediated re- 
laxation in vivo. Reactive hyperaemia induced 
dilatation of all seven vein grafts studied, with a mean 
12% increase in diameter assessed by ultrasound. 122 
Effect of stretch on endothelial cells 
In addition to wall shear stress, pulsatile pressure 
generates a cyclic circumferential and radial strain on 
the newly implanted vein graft (Fig. 1). Studies in 
animal models have suggested an association between 
the medial thickening that takes place following vein 
grafting and increased circumferential s t ress .  26'41"42 By 
externally supporting the vein grafts, and thereby off- 
setting increases in circumferential stress, this medial 
thickening is avoided. 12g Difficulty in measuring this 
stress in vivo has meant hat little information is avail- 
able about h e importance ofthis haemodynamic force 
in man. The effect of this stretch on endothelial cells 
has been relatively little investigated in comparison 
to that of shear stress. Circumferential cyclic strain 
induces morphological changes, such as elongation 
and transverse alignment of cultured endothelial 
cel ls .  ~24-126 Circumferential stretch also stimulates mod- 
ulation of ion channels and protein kinase activity. 127' 
~2g When circumferential stretch is combined with shear 
stress, as occurs in vivo, there is a synergistic effect, 
with enhanced stress fibre size and alignment. 129 In 
addition, cyclic stretch has been shown to alter the 
synthesis of some endothelial products uch as t-PA, 
PGI2, endothelin and nitric oxide. 125'13°'76 
Concern that observation made in animal models 
or on cultured cells may be unrepresentative of the in 
vivo situation has led a number of groups to develop 
whole vessel in vitro models in which vessels can be 
exposed to flow. A recent study using an in vitro model 
of vein bypass uggests that circumferential and radial 
deformation may be responsible for stimulating much 
more rapid changes in leukocyte adhesins in vein 
grafts in vivo than described for cultured endothelial 
cells exposed to shear stress. TM Circumferential nd 
radial deformation were responsible for a two-fold 
increase in ICAM-1 concentration and a three-fold 
reduction in VCAM-1 concentration following only 
45 min of arterial flow. Such changes could have an 
important influence on leukocyte adhesion. Firm ad- 
hesion of leukocytes to the endothelium depends on 
the endothelial expression of ICAM-1 and VCAM-1. 
ICAM-1 interacts with leukocytes expressing CD11a/ 
CD18 or CD11b/CD18, whereas VCAM-1 binds leu- 
kocytes via VLA-4.132 CD11a/CD18 and CD11b/CD18 
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Fig. 3. The pathway of fibrinogen mediated vasorelaxation in saphenous vein. A hypothetical pathway for smooth muscle cell proliferation 
is included. 
are expressed on both neutrophils and monocytes, 
whereas VLA-4 is present on monocytes and lym- 
phocytes. 132 Whether the rapid changes in ICAM-1 and 
VCAM-1 can alter leukocyte adhesion in the absence 
of changes in the selectins or soluble factors favouring 
leukocyte adhesion is unclear; however, the abundant 
P-selectin present on unstimulated saphenous vein 
endothelium suggests this may be the case. If so, the 
increase in ICAM-1 is likely to favour binding of 
leukocytes expressing CD11a/CD18 or CDllb/CD18, 
whereas the decrease in VCAM-1 will deter adhesion 
of leukocyte xpressing VLA-4. 
F ibr inogen-endothe l ia l  Interact ions 
As discussed above, plasma fibrinogen concentration 
has been identified as a powerful predictor of vein 
graft stenosis. Experimental studies have suggested 
two possible mechanisms to explain this association. 
In cultured cells fibrinogen facilitates leukocyte ad- 
hesion to and transmigration across the endo- 
thelium. 133'134 Accumulated leukocytes may then 
release products favouring uncontrolled smooth 
muscle cell proliferation. Fibrinogen has also 
been demonstrated to interact with saphenous vein 
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endothelium in a signalling pathway involving K + 
channel and tyrosine kinase activation to induce 
changes in smooth muscle cell function, including 
vasorelaxationY Fibrinogen appears to bind, at least 
in part, to the adhesin ICAM-1, which in vitro is 
upregulated rapidly in response to arterial flow, as 
is the fibrinogen-mediated vasorelaxation. ~3I'I35 This 
fibrinogen-!CAM-1 pathway may also be linked to a 
pathway stimulating smooth muscle proliferation (Fig. 
3). 
differential binding of leukocyte subtypes. Al- 
ternatively, direct effect of haemodynamic forces on the 
endothelium by influencing the release of endothelial 
products may be more important. 
In conclusion, there is good evidence for a role of 
haemodynamic forces in the development of intimal 
hyperplasia: possible mechanisms include control of 
leukocyte accumulation, thrombosis and directly on 
endothelial release of smooth muscle cell mitogens. It
is likely that direct effects of these forces on smooth 
muscle cells also play an important effect. 
Haemodynamic Forces and Soluble Factors 
The endothelium can secrete a number of soluble 
factors which have potentially beneficial effects on 
vein grafts. The effects of nitric oxide, including vaso- 
relaxation, inhibition of leukocyte and platelet ad- 
hesion and smooth muscle proliferation, have been 
discussed above. The prostaglandins, particularly PG 
I2, also have important influences on the interactions 
of the endothelium with blood constituents and the 
underlying media. PG 12 causes  medial smooth muscle 
relaxation, as well as inhibiting platelet activation and 
aggregation, y° Studies in vitro suggest that these likely 
beneficial effects hould be exaggerated in vein grafts 
exposed to pulsatile flow. Both nitric oxide and PGI2 
release is increased in response to shear stress and 
cyclic deformation. 1°8'125 Such effects may be important 
in vivo to counterbalance similar upregulation of 
smooth muscle mitogenes such as PDGF and fibroblast 
growth factor, which are also produced by the endo- 
thelium and upregulated by shear stress. 112'113'136 
Relationship Between Endothelial Responses to 
Haemodynamic Forces and Intimal Hyperplasia 
The pathogenic mechanisms underlying intimal hy- 
perplasia are complex and still incompletely un- 
derstood. 2y Therefore, relating these changes in 
endothelial functions in response to different haemo- 
dynamic forces to the smooth muscle proliferation, 
migration and secretion of extracellular matrix char- 
acteristic of intimal hyperplasia is purely speculative. 
Changes in the localised control of thrombosis and 
leukocyte adhesion may have important implications 
following vein grafting. For instance, localised re- 
duction in shear stress is likely to favour leukocyte and 
platelet accumulation, i  the absence of modulation of 
endothelial products controlling these vents. Changes 
in the type of leukocyte adhesin expressed may favour 
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